Dr. Barry Dworkin

Interesting laboratory study on how blood type A antigens on respiratory cells’ surface may provide another way for SARS-CoV-2 to enter the body increasing infection risk. However, no clinical outcome data as this looked only at in vitro effects.

Medical Mythbusting Commentary for March 9, 2021

Source:
Why blood type A may increase COVID-19 risk

Reference:
The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A

Related posts:

  1. In vitro study shows mouthwash component has antiviral effect against SARS-CoV2. However that is a long way away from any clinical use if ever.
  2. Headline: “Scientists find potential cure for COVID-related loss of smell.” Not so fast. It concludes that greater improvement with treatment was noted compared to placebo but “there was no subjective olfactory improvement over placebo.”
  3. Universal flu vaccine for prevention and treatment to enter human trials
  4. Excellent basic science study looks at certain viruses as a contributing factor to the development of Alheimer’s